CN102526075B - 一种脂溶性维生素冻干针剂及其制备方法 - Google Patents
一种脂溶性维生素冻干针剂及其制备方法 Download PDFInfo
- Publication number
- CN102526075B CN102526075B CN201010575712.8A CN201010575712A CN102526075B CN 102526075 B CN102526075 B CN 102526075B CN 201010575712 A CN201010575712 A CN 201010575712A CN 102526075 B CN102526075 B CN 102526075B
- Authority
- CN
- China
- Prior art keywords
- vitamin
- freeze
- fat
- injection
- insulation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 229940088594 vitamin Drugs 0.000 title claims abstract description 40
- 229930003231 vitamin Natural products 0.000 title claims abstract description 40
- 235000013343 vitamin Nutrition 0.000 title claims abstract description 40
- 239000011782 vitamin Substances 0.000 title claims abstract description 40
- 150000003722 vitamin derivatives Chemical class 0.000 title claims abstract description 40
- 238000002347 injection Methods 0.000 title claims abstract description 33
- 239000007924 injection Substances 0.000 title claims abstract description 33
- 238000002360 preparation method Methods 0.000 title claims abstract description 22
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 40
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims abstract description 36
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims abstract description 30
- VYGQUTWHTHXGQB-FFHKNEKCSA-N Retinol Palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C VYGQUTWHTHXGQB-FFHKNEKCSA-N 0.000 claims abstract description 26
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 claims abstract description 24
- 229930195725 Mannitol Natural products 0.000 claims abstract description 24
- 235000010355 mannitol Nutrition 0.000 claims abstract description 24
- 239000000594 mannitol Substances 0.000 claims abstract description 24
- 229920001213 Polysorbate 20 Polymers 0.000 claims abstract description 18
- 239000011772 phylloquinone Substances 0.000 claims abstract description 18
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 claims abstract description 18
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 claims abstract description 18
- ABSPRNADVQNDOU-UHFFFAOYSA-N Menaquinone 1 Natural products C1=CC=C2C(=O)C(CC=C(C)C)=C(C)C(=O)C2=C1 ABSPRNADVQNDOU-UHFFFAOYSA-N 0.000 claims abstract description 17
- 235000019175 phylloquinone Nutrition 0.000 claims abstract description 17
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 claims abstract description 17
- MBWXNTAXLNYFJB-NKFFZRIASA-N phylloquinone Chemical compound C1=CC=C2C(=O)C(C/C=C(C)/CCC[C@H](C)CCC[C@H](C)CCCC(C)C)=C(C)C(=O)C2=C1 MBWXNTAXLNYFJB-NKFFZRIASA-N 0.000 claims abstract description 17
- 229960001898 phytomenadione Drugs 0.000 claims abstract description 17
- MECHNRXZTMCUDQ-RKHKHRCZSA-N vitamin D2 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)/C=C/[C@H](C)C(C)C)=C\C=C1\C[C@@H](O)CCC1=C MECHNRXZTMCUDQ-RKHKHRCZSA-N 0.000 claims abstract description 16
- MECHNRXZTMCUDQ-UHFFFAOYSA-N Vitamin D2 Natural products C1CCC2(C)C(C(C)C=CC(C)C(C)C)CCC2C1=CC=C1CC(O)CCC1=C MECHNRXZTMCUDQ-UHFFFAOYSA-N 0.000 claims abstract description 15
- 229930003427 Vitamin E Natural products 0.000 claims abstract description 15
- 229960002061 ergocalciferol Drugs 0.000 claims abstract description 15
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims abstract description 15
- 235000001892 vitamin D2 Nutrition 0.000 claims abstract description 15
- 239000011653 vitamin D2 Substances 0.000 claims abstract description 15
- 235000019165 vitamin E Nutrition 0.000 claims abstract description 15
- 239000011709 vitamin E Substances 0.000 claims abstract description 15
- 229940046009 vitamin E Drugs 0.000 claims abstract description 15
- VYGQUTWHTHXGQB-UHFFFAOYSA-N Retinol hexadecanoate Natural products CCCCCCCCCCCCCCCC(=O)OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C VYGQUTWHTHXGQB-UHFFFAOYSA-N 0.000 claims abstract description 13
- 235000019172 retinyl palmitate Nutrition 0.000 claims abstract description 13
- 229940108325 retinyl palmitate Drugs 0.000 claims abstract description 13
- 239000011769 retinyl palmitate Substances 0.000 claims abstract description 13
- 238000003756 stirring Methods 0.000 claims description 26
- 238000009413 insulation Methods 0.000 claims description 20
- 229920001214 Polysorbate 60 Polymers 0.000 claims description 17
- 238000010792 warming Methods 0.000 claims description 15
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 15
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 10
- 239000000243 solution Substances 0.000 claims description 10
- 239000000203 mixture Substances 0.000 claims description 9
- 239000008215 water for injection Substances 0.000 claims description 8
- JGSARLDLIJGVTE-UHFFFAOYSA-N 3,3-dimethyl-7-oxo-6-[(2-phenylacetyl)amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid Chemical compound O=C1N2C(C(O)=O)C(C)(C)SC2C1NC(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-UHFFFAOYSA-N 0.000 claims description 5
- 230000033228 biological regulation Effects 0.000 claims description 5
- 239000003610 charcoal Substances 0.000 claims description 5
- 239000003814 drug Substances 0.000 abstract description 5
- 229960004756 ethanol Drugs 0.000 abstract description 2
- 235000019441 ethanol Nutrition 0.000 abstract description 2
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 abstract description 2
- 229920000053 polysorbate 80 Polymers 0.000 abstract description 2
- 235000011121 sodium hydroxide Nutrition 0.000 abstract description 2
- 239000000244 polyoxyethylene sorbitan monooleate Substances 0.000 abstract 1
- 229940068968 polysorbate 80 Drugs 0.000 abstract 1
- 239000000047 product Substances 0.000 description 19
- 239000003963 antioxidant agent Substances 0.000 description 6
- 230000003078 antioxidant effect Effects 0.000 description 6
- 235000006708 antioxidants Nutrition 0.000 description 6
- 238000000034 method Methods 0.000 description 6
- 239000002904 solvent Substances 0.000 description 6
- 238000012360 testing method Methods 0.000 description 6
- 239000002671 adjuvant Substances 0.000 description 4
- 239000006184 cosolvent Substances 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 2
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 2
- 239000000470 constituent Substances 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 238000012216 screening Methods 0.000 description 2
- GEHJYWRUCIMESM-UHFFFAOYSA-L sodium sulfite Chemical compound [Na+].[Na+].[O-]S([O-])=O GEHJYWRUCIMESM-UHFFFAOYSA-L 0.000 description 2
- 230000003381 solubilizing effect Effects 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 235000019155 vitamin A Nutrition 0.000 description 2
- 239000011719 vitamin A Substances 0.000 description 2
- 229940045997 vitamin a Drugs 0.000 description 2
- QIJRTFXNRTXDIP-UHFFFAOYSA-N (1-carboxy-2-sulfanylethyl)azanium;chloride;hydrate Chemical compound O.Cl.SCC(N)C(O)=O QIJRTFXNRTXDIP-UHFFFAOYSA-N 0.000 description 1
- 206010003694 Atrophy Diseases 0.000 description 1
- 206010018910 Haemolysis Diseases 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000037444 atrophy Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 229960001305 cysteine hydrochloride Drugs 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 230000008588 hemolysis Effects 0.000 description 1
- 230000002949 hemolytic effect Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000000693 micelle Substances 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 230000010494 opalescence Effects 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- MBWXNTAXLNYFJB-LKUDQCMESA-N phylloquinone Chemical compound C1=CC=C2C(=O)C(C/C=C(C)/CCCC(C)CCCC(C)CCCC(C)C)=C(C)C(=O)C2=C1 MBWXNTAXLNYFJB-LKUDQCMESA-N 0.000 description 1
- 238000005086 pumping Methods 0.000 description 1
- 238000012954 risk control Methods 0.000 description 1
- 235000010265 sodium sulphite Nutrition 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
Abstract
Description
Claims (2)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201010575712.8A CN102526075B (zh) | 2010-12-07 | 2010-12-07 | 一种脂溶性维生素冻干针剂及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201010575712.8A CN102526075B (zh) | 2010-12-07 | 2010-12-07 | 一种脂溶性维生素冻干针剂及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102526075A CN102526075A (zh) | 2012-07-04 |
CN102526075B true CN102526075B (zh) | 2014-04-30 |
Family
ID=46334899
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201010575712.8A Active CN102526075B (zh) | 2010-12-07 | 2010-12-07 | 一种脂溶性维生素冻干针剂及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102526075B (zh) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102743394A (zh) * | 2012-07-30 | 2012-10-24 | 刘时灵 | 复合脂溶性维生素注射液 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101073580A (zh) * | 2007-06-22 | 2007-11-21 | 北京润德康医药技术有限公司 | 复合维生素注射液及其制备方法 |
CN101606939B (zh) * | 2009-07-27 | 2010-12-01 | 徐新盛 | 一种脂溶性维生素冻干粉针及其制备方法 |
CN101711769A (zh) * | 2009-11-23 | 2010-05-26 | 北京京卫信康医药科技发展有限公司 | 一种稳定的注射用12种复合维生素组合物及其制备方法 |
-
2010
- 2010-12-07 CN CN201010575712.8A patent/CN102526075B/zh active Active
Also Published As
Publication number | Publication date |
---|---|
CN102526075A (zh) | 2012-07-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102068453B (zh) | 一种稳定的复合维生素组合物及其制备方法 | |
KR20070112725A (ko) | 우수한 안정성을 갖는 도세탁셀 함유 주사제 조성물 및이의 제조방법 | |
CN102973528B (zh) | 骨化三醇固体脂质分散体及其制备方法 | |
CN102525963B (zh) | 一种硫酸奈替米星冻干粉针及其制备方法 | |
CN100372534C (zh) | 托拉塞米冻干制剂及制备方法 | |
CN102813632A (zh) | 一种稳定的胸腺法新制剂及其制备方法 | |
CN105688220A (zh) | 一种含丁苯酞与新型增溶剂的药物组合物 | |
CN104414983A (zh) | 一种注射用福沙匹坦二甲葡胺无菌冻干粉末及其制备工艺 | |
CN103040770B (zh) | 一种诺卡沙星冻干粉针剂的制备方法 | |
CN102526075B (zh) | 一种脂溶性维生素冻干针剂及其制备方法 | |
CN102342931B (zh) | 替莫唑胺的可注射的胃肠外用药物制剂及其制备方法 | |
CN106137985A (zh) | 一种稳定的棕榈酸帕利哌酮长效制剂 | |
CN102488650B (zh) | 一种环磷腺苷药物组合物及其制备方法 | |
CN101584659B (zh) | 一种多西他赛药物组合物注射剂及其制备方法 | |
CN102784382A (zh) | 一种阿加曲班药物组合物及其制备方法和应用 | |
CN101940557B (zh) | 一种脂溶性维生素冻干粉针的制备方法 | |
CN104688676A (zh) | 穿心莲内酯浓缩型液体组方及其医药用途 | |
CN104606209A (zh) | 一种注射用复方维生素药物组合物及其制备方法 | |
WO2023025291A1 (zh) | 冻干制剂溶液及冻干制剂、方法和用途 | |
CN103494776B (zh) | 枸橼酸他莫昔芬冻干粉针 | |
CN102885775A (zh) | 一种炎琥宁无菌粉及其制备方法 | |
CN109568277A (zh) | 枸橼酸在制备帕瑞昔布钠冻干制剂组合物中的应用及其组合物和制备方法 | |
CN103520186B (zh) | 一种注射用脂溶性维生素的药物组合物及其制备方法 | |
CN102552288A (zh) | 一种稳定的复合脂溶性维生素组合物及其制备方法 | |
CN103735522B (zh) | 一种炎琥宁冻干粉针及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C56 | Change in the name or address of the patentee | ||
CP03 | Change of name, title or address |
Address after: 17 No. 856099, Tibet autonomous region, city Zedang town Sanxiang Road Patentee after: Haisike Pharmaceutical Group Limited by Share Ltd Patentee after: Liaoning Haisco Pharmaceutical Co., Ltd. Patentee after: Sichuan Haisco Pharmaceutical Co.,Ltd. Address before: The 856000 Tibet autonomous region in southern area of Zedang town Xiang Qu Road No. 8 Patentee before: Tibet Haisco Pharmaceutical Group Co., Ltd. Patentee before: Liaoning Haisco Pharmaceutical Co., Ltd. Patentee before: Sichuan Haisco Pharmaceutical Co.,Ltd. |
|
EE01 | Entry into force of recordation of patent licensing contract |
Application publication date: 20120704 Assignee: Chengdu Tiantaishan Pharmaceutical Co., Ltd. Assignor: Haisike Pharmaceutical Group Limited by Share Ltd|Liaoning Haisco Pharmaceutical Co., Ltd.|Sichuan Haisco Pharmaceutical Co.,Ltd. Contract record no.: 2016510000032 Denomination of invention: Fat-soluble vitamin freeze-dried injection and preparation method thereof Granted publication date: 20140430 License type: Common License Record date: 20161212 |
|
LICC | Enforcement, change and cancellation of record of contracts on the licence for exploitation of a patent or utility model | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20170906 Address after: 17 No. 856099, Tibet autonomous region, city Zedang town Sanxiang Road Patentee after: Haisike Pharmaceutical Group Limited by Share Ltd Address before: 17 No. 856099, Tibet autonomous region, city Zedang town Sanxiang Road Co-patentee before: Liaoning Haisco Pharmaceutical Co., Ltd. Patentee before: Haisike Pharmaceutical Group Limited by Share Ltd Co-patentee before: Sichuan Haisco Pharmaceutical Co.,Ltd. |
|
EM01 | Change of recordation of patent licensing contract | ||
EM01 | Change of recordation of patent licensing contract |
Change date: 20190410 Contract record no.: 2016510000032 Assignor after: Haisike Pharmaceutical Group Limited by Share Ltd Assignor before: Haisike Pharmaceutical Group Limited by Share Ltd. Assignor before: Liaoning sea CISCO Pharmaceutical Co. Ltd. Assignor before: Sichuan sea CISCO Pharmaceutical Co. Ltd. |